GT
CRDF icon

Glenview Trust’s Cardiff Oncology CRDF Stock Holding History

Glenview Trust’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.1K Hold
43,128
– – ﹤0.01% 514
2026
Q1 		$69.9K Hold
43,128
– – ﹤0.01% 496
2025
Q4 		$121K Hold
43,128
– – ﹤0.01% 485
2025
Q3 		$88.8K Hold
43,128
– – ﹤0.01% 484
2025
Q2 		$136K Buy
43,128
+19,150
+80% +$58.4K ﹤0.01% 497
2025
Q1 		$75.3K Hold
23,978
– – ﹤0.01% 472
2024
Q4 		$104K Buy
+23,978
New +$74.9K ﹤0.01% 476

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Glenview Trust's CRDF Position: Q2 2026 in Review

Glenview Trust held its Cardiff Oncology (CRDF) position steady in Q2 2026 at 43,128 shares worth $56.1K. The position accounts for ﹤0.01% of the portfolio, ranked #514.

Glenview Trust first reported a position in CRDF in Q4 2024 and has held it in 7 quarters since. The position peaked at $136K in Q2 2025. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Glenview Trust held 43,128 shares of Cardiff Oncology worth $56.1K as of Q2 2026.
  • Glenview Trust left its Cardiff Oncology share count unchanged in Q2 2026.
  • Cardiff Oncology made up ﹤0.01% of Glenview Trust's portfolio in Q2 2026, its #514 holding.
  • Glenview Trust first reported a position in Cardiff Oncology in Q4 2024 and has held it in 7 quarters since.
  • Glenview Trust's Cardiff Oncology position peaked at $136K in Q2 2025.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.